FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments, today announced that Dr. Jan H. Egberts, NovaDel’s President and Chief Executive Officer, is scheduled to meet with investors and to provide a corporate update at the upcoming Rodman & Renshaw 4th Annual Global Healthcare Conference. This event will be held May 14 – 15, 2007, in Monte Carlo, Monaco. Details regarding NovaDel’s presentation at this event are as follows:
